Novacyt « Terug naar discussie overzicht

Waar beleggen jullie nog meer in

2.899 Posts, Pagina: « 1 2 3 4 5 6 ... 39 40 41 42 43 44 45 46 47 48 49 ... 141 142 143 144 145 » | Laatste

Omlaag ↓

Hansvdz 22 juni 2020 10:28

quote:
RW1963 schreef op 22 juni 2020 09:38:
[...]

Ik ben hier vanmorgen ook ingestapt. Sindsdien is het mooi stijgende ;-)
Wat zijn reële verwachtingen voor dit aandeel ?

Wat is je gak op dit aandeel? Kan vandaag wel eens naar de 0.26 gaan.

[verwijderd] 22 juni 2020 11:46

XSPA in de voorbeurs al boven de $ 5. Gaat hopelijk een mooie week worden!

RW1963 22 juni 2020 12:09

quote:
Hansvdz schreef op 22 juni 2020 10:28:
[...]

Wat is je gak op dit aandeel? Kan vandaag wel eens naar de 0.26 gaan.

Gekocht op € 0,22. € 0,26 al aangeraakt.

[verwijderd] 22 juni 2020 12:21

Deze in de gaten houden:

Ideanomics, Inc. (IDEX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist

Quote Lookup

2.2200+0.1600 (+7.77%)
At close: June 19 4:00PM EDT
2.6500 +0.43 (19.37%)
Before hours: 6:18AM EDT

[verwijderd] 22 juni 2020 12:23

En GNUS, zit toch ook weer in een stijgende lijn.

Genius Brands International, Inc. (GNUS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist

Quote Lookup

2.9400+0.1500 (+5.38%)
At close: June 19 4:00PM EDT
3.09 +0.15 (5.10%)
Before hours: 6:21AM EDT

[verwijderd] 22 juni 2020 12:25

XSPA ziet er voorbeurs ook goed uit.

XpresSpa Group Inc (XSPA)

NASDAQ

Melding aanmaken
Voeg toe aan Portfolio
4,8800 -0,1500 -2,98%
19/06 - Gesloten. Valuta in USD ( Algemene voorwaarden )
Voorbeurs 5,1000 +0,2200 +4,5082% 11:58:58 - Real-time Data

[verwijderd] 22 juni 2020 12:26

Dit ziet er weer na een veelbelovende week uit, succes.

[verwijderd] 22 juni 2020 12:46

En dan nog maar 1:

Kitov Pharma Ltd (KTOV)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist

Quote Lookup

0.5690+0.0940 (+19.79%)
At close: June 19 4:00PM EDT
0.70 +0.131 (23.02%)
Before hours: 6:42AM EDT

Eric61 22 juni 2020 13:47

ITM even snel van 3.60 naar 2.50. Zo heb je een dikke plus en even snel is het weer foetsie. Wijselijk weer niets verkocht met mijn stomme kop.

Hansvdz 22 juni 2020 13:48

quote:
RW1963 schreef op 22 juni 2020 12:09:
[...]

Gekocht op € 0,22. € 0,26 al aangeraakt.

Ook al verkocht?

[verwijderd] 22 juni 2020 13:50

BIOC vorige week aangeschaft 0,80, er zijn verschillende links met Thermofischer, deze kon weleens gaan knallen deze week met nieuws.

Biocept Inc (BIOC)

NASDAQ

Melding aanmaken
Voeg toe aan Portfolio
0,8685 -0,0815 -8,58%
19/06 - Gesloten. Valuta in USD ( Algemene voorwaarden )
Voorbeurs 0,9275 +0,0590 +6,7933% 13:47:46 - Real-time Data
Type: Aandeel
Markt: Verenigde Staten
ISIN: US09072V4023

[verwijderd] 22 juni 2020 13:57

DBT heeft zeker toekomst, momenteel goed voor dag trading.

[verwijderd] 22 juni 2020 14:12

Deze kan weleens vlot naar de 2,- gaan deze week:

Biocept, Inc. (BIOC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist

Quote Lookup

0.8685-0.0815 (-8.58%)
At close: June 19 4:00PM EDT
0.97 +0.1015 (11.69%)
Before hours: 8:10AM EDT

[verwijderd] 22 juni 2020 14:19

quote:
KC 1965 schreef op 22 juni 2020 14:12:
Deze kan weleens vlot naar de 2,- gaan deze week:

Biocept, Inc. (BIOC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist

Quote Lookup

0.8685-0.0815 (-8.58%)
At close: June 19 4:00PM EDT
0.97 +0.1015 (11.69%)
Before hours: 8:10AM EDT

\
en waarom??

[verwijderd] 22 juni 2020 14:28

Bekijk hun forum, staan interessante dingen.

[verwijderd] 22 juni 2020 14:47

Ik hoop hier vandaag gunstig in te stappen:

Ideanomics Inc (IDEX)

NASDAQ

Melding aanmaken
Voeg toe aan Portfolio
2,2200 +0,1600 +7,77%
19/06 - Gesloten. Valuta in USD ( Algemene voorwaarden )
Voorbeurs 2,8200 +0,6000 +27,03% 14:45:50 - Real-time Data

[verwijderd] 22 juni 2020 14:50

Healthcare | On the Move
Biocept's COVID-19 testing kit now available for physician ordering
Jun. 22, 2020 8:27 AM ET|About: Biocept, Inc. (BIOC)|By: Mamta Mayani, SA News Editor
Biocept (NASDAQ:BIOC) announces the availability of 10,000 nasopharyngeal specimen collection kits for RT-PCR testing for COVID-19 for physician ordering.

Collected specimens will be shipped overnight to Biocept's, CLIA-certified and BSL-2 safety level laboratory in San Diego with results returned in an estimated 24 to 48 hours.

Biocept-developed RT-PCR COVID-19 kits are expected to be available in Q3.

Shares are up 7% premarket.

[verwijderd] 22 juni 2020 14:54

Biocept Announces the Availability of 10,000 Specimen Collection Kits for RT-PCR COVID-19 Testing
PR Newswire PR NewswireJune 22, 2020
SAN DIEGO, June 22, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, announces the availability of 10,000 nasopharyngeal specimen collection kits for RT-PCR testing for SAR-CoV-2 (COVID-19) for physician ordering. Collected specimens will be shipped overnight to Biocept's high-complexity, CLIA-certified, CAP-accredited and BSL-2 safety level laboratory in San Diego with results returned to ordering physicians in an estimated 24 to 48 hours.

Biocept Logo (PRNewsFoto/Biocept, Inc.)
Biocept Logo (PRNewsFoto/Biocept, Inc.)
More
"As previously reported, securing specimen collection kits to conduct RT-PCR COVID-19 testing has been challenging both for Biocept and other providers. We have solved our initial supply chain challenge by obtaining the swabs, reagents and other components of these kits, assembling them, and making them available for physician ordering," said Michael Nall, Biocept's President and CEO. "We continue to develop our own specimen collection media, which will allow us to further control our supply chain. We expect these Biocept-developed RT-PCR COVID-19 kits to be available in the third quarter of 2020.

"We are pleased to be offering this testing during the continuing pandemic, with RT-PCR testing providing the most accurate results for detecting active COVID-19 virus," he added. "As previously announced, we expanded our relationship with Thermo Fisher Scientific to run these tests on their FDA-approved for emergency-use authorization, or EUA, TaqPath™ molecular diagnostic platform. We believe we have a distinct advantage in performing RT-PCR COVID-19 testing given our rapid turnaround time, which is faster than many other labs."

Information for physician ordering of RT-PCR COVID-19 specimen collection kits from Biocept is available on the company website at www.biocept.com or by contacting customer service at 888-332-7729 or customerservice@biocept.com.

About Biocept
Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. The Company's patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. Additionally, Biocept is offering nationwide COVID-19 polymerase chain reaction (PCR) testing to support public health efforts during this unprecedented pandemic. For more information, please visit www.biocept.com.

Forward-Looking Statements Disclaimer Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements regarding our development of our own specimen collection media and that such development will allow us to control all aspects of the supply chain, our expectation that Biocept-developed RT-PCR COVID-19 kits will be available in the third quarter of 2020, the relative accuracy of RT-PCR testing, our ability to perform RT-PCR COVID-19 testing faster than many other labs, the ability of our platform to identify cancer mutations and alterations, and the ability of our technologies to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our Securities and Exchange Commission (SEC) filings. The effects of such risks and uncertainties could cause actual results to differ materially from the forward-looking statements contained in this release. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this press release except as required by law. You are advised to review our filings with the SEC, which can be accessed over the Internet at the SEC's website located at www.sec.gov.

Investor Contact:
LHA Investor Relations

[verwijderd] 22 juni 2020 16:07

quote:
KC 1965 schreef op 22 juni 2020 14:47:
Ik hoop hier vandaag gunstig in te stappen:

Ideanomics Inc (IDEX)

NASDAQ

Melding aanmaken
Voeg toe aan Portfolio
2,2200 +0,1600 +7,77%
19/06 - Gesloten. Valuta in USD ( Algemene voorwaarden )
Voorbeurs 2,8200 +0,6000 +27,03% 14:45:50 - Real-time Data

Nog gelukt? Die gaat hard nu..

[verwijderd] 22 juni 2020 16:26

XSPA schoot net ineens naa $ 5,30!

2.899 Posts, Pagina: « 1 2 3 4 5 6 ... 39 40 41 42 43 44 45 46 47 48 49 ... 141 142 143 144 145 » | Laatste

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd	9 mei 2024 10:16
Koers	0,773
Verschil	+0,005 (+0,65%)
Hoog	0,780
Laag	0,762
Volume	25.609
Volume gemiddeld	190.243
Volume gisteren	74.386

Waar beleggen jullie nog meer in

Meedoen aan de discussie?

Direct naar Forum

Detail

Novacyt nieuws meer